Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases

NCT07666841 · tracked via the Priya Life Science Israel tracker

Sponsor

Tel-Aviv Sourasky Medical Center

Phase

Not applicable

Started

2026-07-01

Last updated

2026-09-24

Condition(s) studied

COPD (Chronic Obstructive Pulmonary Disease)RehabilitationBronchiectasis AdultPulmonary Arterial Hypertension (PAH)Interstitial Lung Disease (ILD)

Investigational drug(s) / intervention(s)

Tele-Rehabilitation

Tele-Rehabilitation: Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants. The sessions include: 1. Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2. Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided pulse oximeter. 3. Comprehensive Education: Guidance on lifestyle, nutrition, and physical activity. 4. Digital Support: The app provides activity tracking, symptom logging, session reminders, and guided home exercises. At the end of each session, every participant receives a personalized exercise plan based on their performance and preferences, which is displayed in the app.

Study summary

Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups.

This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups:

1. The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center.
2. The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions: * COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year. * Interstitial lung disease with an FVC below 80% or a DLCO below 60%. * Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%. * Pulmonary arterial hypertension. 2. Willingness to initiate a PR or Tele-PR (TPR) programs. 3. Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment. 4. Agree to participate, with signed informed consent. Exclusion Criteria: 1. Uncontrolled comorbidity (e.g uncontrolled congestive heart failure) 2. Inability to operate the mobile application. 3. Without a mobile device or computer. 4. A hospitalization in the 2-months prior to randomization. 5. Completed PR program in the last 12 months. 6. Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance 7. Pregnancy 8. Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.

Primary outcome measure(s)

Adherence to pulmonary rehabilitation Between the Study Groups — Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.
Adherence will be defined as initiation of pulmonary rehabilitation in 3 months from study inclusion and completion of at least 50% (12 sessions) of the program (regular/remote based on allocation) within 6 months from inclusion.

Trial sites (2)

Facility	City	Region	Status
Barzilai Medical Center	Ashkelon	Israel	Recruiting
Tel Aviv Sourasky Medical Center	Tel Aviv	Israel	Recruiting

More Tel-Aviv Sourasky Medical Center trials in Israel

Freezing of Gait - Clinical Outcomes Assessment Recruiting

EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC) Recruiting

Blind Vs US Guided Manual Pressure Points Active, not recruiting

Tele-Pulmonary Rehabilitation For COPD Patients Living in Peripheral Areas Recruiting

Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers Starting soon

Other trials for the same condition

Tele-Pulmonary Rehabilitation For COPD Patients Living in Peripheral Areas Recruiting

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes Active, not recruiting

Improving Adherence to COPD Treatments in Primary Care Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07666841 on ClinicalTrials.gov ↗ ← All trials in Israel